NeuroSense Therapeutics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
NeuroSense Therapeutics Ltd. (NRSN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate of 100.54% for the 12-month period ending 2023-12-31, per its 6-K filed 2024-06-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate · last filed 2024-06-17
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 12 month |
|---|---|
| 2023-12-31 | 100.54% 6-K · filed 2024-06-17 |
| 2022-12-31 | 93.64% 6-K · filed 2024-06-17 |